S&P 500
(-0.88%) 4 967.23 points
Dow Jones
(0.56%) 37 986 points
Nasdaq
(-2.05%) 15 282 points
Oil
(0.62%) $83.24
Gas
(0.46%) $1.765
Gold
(0.31%) $2 405.50
Silver
(1.25%) $28.74
Platinum
(-1.18%) $943.20
USD/EUR
(-0.06%) $0.939
USD/NOK
(-0.21%) $11.02
USD/GBP
(0.57%) $0.809
USD/RUB
(-0.96%) $93.00

Realtime updates for Coloplast A/S [CBHD.DE]

Exchange: XETRA Industry: Health Care Equipment & Services
Last Updated19 Apr 2024 @ 11:35

0.42% 120.75

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:35):

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature...

Stats
Today's Volume 4.00
Average Volume 479.00
Market Cap 27.13B
EPS €0 ( 2023-09-30 )
Last Dividend €5.00 ( 2023-05-15 )
Next Dividend €0 ( N/A )
P/E 40.38
ATR14 €0 (0.00%)

Coloplast A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Coloplast A/S Financials

Annual 2023
Revenue: €24.50B
Gross Profit: €16.33B (66.64 %)
EPS: €22.21
Q4 2023
Revenue: €6.23B
Gross Profit: €4.13B (66.37 %)
EPS: €5.63
Q3 2023
Revenue: €6.11B
Gross Profit: €4.02B (65.86 %)
EPS: €5.99
Q2 2023
Revenue: €6.11B
Gross Profit: €4.02B (65.86 %)
EPS: €5.99

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0
(N/A)
€15.00
(N/A)
€0
(N/A)
€5.00
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.24 - good (82.42%) | Divividend Growth Potential Score: 3.96 - Decrease likely (20.86%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €1.800 2007-12-19
Last Dividend €5.00 2023-05-15
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 27 --
Total Paid Out €171.20 --
Avg. Dividend % Per Year 0.00% --
Score 3.1 --
Div. Sustainability Score 8.24
Div.Growth Potential Score 3.96
Div. Directional Score 6.10 --
Next Divdend (Est)
(2024-07-12)
€4.49 Estimate 3.50 %
Dividend Stability
0.28 Very Poor
Dividend Score
3.10
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
VVD.DE Ex Dividend Junior 2023-05-09 Annually 0 0.00%
G24.DE Ex Dividend Junior 2023-06-23 Annually 0 0.00%
PAH3.DE Ex Dividend Knight 2023-07-03 Annually 0 0.00%
BIJ.DE Ex Dividend Knight 2023-06-21 Sporadic 0 0.00%
HMSB.DE Ex Dividend Knight 2023-11-09 Annually 0 0.00%
RWE.DE Ex Dividend Knight 2023-05-05 Annually 0 0.00%
CPIA.F No Dividend Player 2023-06-29 Annually 0 0.00%
KHNZ.DE Ex Dividend Knight 2023-08-31 Quarterly 0 0.00%
2M6.DE Ex Dividend Knight 2023-09-21 Quarterly 0 0.00%
TCM1.F Ex Dividend Knight 2023-08-09 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1941.5006.119.17[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4291.5006.359.52[0.1 - 1]
payoutRatioTTM1.175-1.00010.00-10.00[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.2810.800-3.06-2.44[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM10.721.0007.147.14[3 - 30]
operatingCashFlowPerShareTTM27.492.000.8361.672[0 - 30]
freeCashFlowPerShareTTM21.812.0010.0010.00[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6661.0002.232.23[0.2 - 0.8]
operatingProfitMarginTTM0.2751.0006.496.49[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2781.0009.579.57[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score8.24

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM41.281.0005.930[1 - 100]
returnOnEquityTTM0.4292.507.659.52[0.1 - 1.5]
freeCashFlowPerShareTTM21.812.002.7310.00[0 - 30]
dividendYielPercentageTTM2.281.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM27.492.000.8361.672[0 - 30]
payoutRatioTTM1.1751.50010.00-10.00[0 - 1]
pegRatioTTM-2.371.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2401.0006.500[0.1 - 0.5]
Total Score3.96

Coloplast A/S

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators